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Nikhil Mehta, MBBS, Mario Caruso, DO, Syed Rafay Ali Sabzwari, MD, Lohit Garg MD, Jeffrey Gordon, MD, Talha Nazir, MD
Lehigh Valley Health Network, Allentown, Pa.
BACKGROUND
•  Congenital long QT syndrome (LQTS) type 2 is 
associated with an increased risk of ventricular 
arrhythmias and sudden cardiac death. 
•  Risk is increased in the postpartum period, and 
treatment consists of beta-blockers and ICDs in high 
risk patients. 
•  Left cervical ganglion sympathectomy can be considered 
in cases refractory to beta-blocker therapy. 
CASE SUMMARY
INITIAL PRESENTATION: 
•  A 36 year old woman (G5P0313) one month 
postpartum with history of LQTS type 2 presented to 
the ER with syncope and ICD shock from polymorphic 
ventricular tachycardia (PMVT). Her 4 children all have 
LQTS type 2 with class 1 KCNH2 mutation. 
•  During her last pregnancy, she was found to have 
significant QTc prolongation to 628 msec for which she 
underwent subcutaneous ICD implantation. [ECG 1]
•  She was admitted and treated with increasing doses of 
beta-blocker (nadolol) until episodes of PMVT subsided, 
and was finally discharged to outpatient follow up. 
Episodes attributed to increased anxiety and her 
postpartum state.
SUBSEQUENT PRESENTATION:
•  Six months postpartum, she came back with another 
episode of syncope and ICD shock due to PMVT, QTc 
markedly prolonged to 660 msec.[ECG 2]
•  By now she was taking maximum doses of beta-blocker 
(Nadolol), and an anxiolytic, Valium.
DECISION-MAKING
•  Since our patient was 6 months postpartum, markedly 
anxious, and having recurrent PMVT with ICD shocks 
despite maximum doses of nadolol, we elected to pursue 
left T2-T4 cervical and lower stellate ganglion sympathectomy. 
•  This interrupts the release of norepinephrine in the heart, 
thereby reducing symptoms and shortening the QT. 
•  Sympathectomy has been shown to reduce the incidence 
of aborted cardiac arrest and syncope, with mean yearly 
events per patient dropping by as much as 91%. [1, 2]  
A post procedure QTc <500 ms predicts low risk of  
future events.
•  Current guidelines recommend sympathectomy for patients 
with LQTS in whom: (I) ICD therapy is contraindicated or 
refused (Ic), (II) β-blockers are either not effective, not 
tolerated, or contraindicated (Ic), or (III) patients with 
breakthrough events despite β-blockers/ICD (IIa). [3]
•  She successfully underwent the procedure without any 
complications. [ECG 3] 
•  At 12-month follow up, QTc measured 510 msec. [ECG 4]
CONCLUSION
•  This case highlights the management strategies for 
ventricular arrhythmias in patients with LQTS type 2 in  
the postpartum period. 
•  When patients experience recurrent malignant arrhythmias 
despite β-blocker use, left cervical sympathectomy could 
be considered to prevent future events.
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2. Subsequent Presentation: QTc prolonged to 660 msec.
4.  At 12 month follow up: QTc measured 510 msec.3.  Immediately post sympathectomy: QTc improved to 
545 msec.
1. Baseline ECG: QTc prolonged to 628 msec.




























CA n=22 CA/SD n=8/1
-59%
(mean CER 0.32+0.64) (mean CER 0.07+0.27)
-78%
Effect of sympathectomy on cardiac event 
rates (CER) in 78 patients under β-blocker 
therapy before and after procedure. [1]
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